Attenuation of TGFBR2 expression and tumour progression in prostate cancer involve diverse hypoxia-regulated pathways

Abstract Background Dysregulation of transforming growth factor β (TGF-β) signaling and hypoxic microenvironment have respectively been reported to be involved in disease progression in malignancies of prostate. Emerging evidence indicates that downregulation of TGFBR2, a pivotal regulator of TGF-β...

Full description

Bibliographic Details
Main Authors: Hui Zhou, Guanqing Wu, Xueyou Ma, Jun Xiao, Gan Yu, Chunguang Yang, Nan Xu, Bao Zhang, Jun Zhou, Zhangqun Ye, Zhihua Wang
Format: Article
Language:English
Published: BMC 2018-04-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13046-018-0764-9
_version_ 1828485984389431296
author Hui Zhou
Guanqing Wu
Xueyou Ma
Jun Xiao
Gan Yu
Chunguang Yang
Nan Xu
Bao Zhang
Jun Zhou
Zhangqun Ye
Zhihua Wang
author_facet Hui Zhou
Guanqing Wu
Xueyou Ma
Jun Xiao
Gan Yu
Chunguang Yang
Nan Xu
Bao Zhang
Jun Zhou
Zhangqun Ye
Zhihua Wang
author_sort Hui Zhou
collection DOAJ
description Abstract Background Dysregulation of transforming growth factor β (TGF-β) signaling and hypoxic microenvironment have respectively been reported to be involved in disease progression in malignancies of prostate. Emerging evidence indicates that downregulation of TGFBR2, a pivotal regulator of TGF-β signaling, may contribute to carcinogenesis and progression of prostate cancer (PCa). However, the biological function and regulatory mechanism of TGFBR2 in PCa remain poorly understood. In this study, we propose to investigate the crosstalk of hypoxia and TGF-β signaling and provide insight into the molecular mechanism underlying the regulatory pathways in PCa. Methods Prostate cancer cell lines were cultured in hypoxia or normoxia to evaluate the effect of hypoxia on TGFBR2 expression. Methylation specific polymerase chain reaction (MSP) and demethylation agents was used to evaluate the methylation regulation of TGFBR2 promoter. Besides, silencing of EZH2 via specific siRNAs or chemical inhibitor was used to validate the regulatory effect of EZH2 on TGFBR2. Moreover, we conducted PCR, western blot, and luciferase assays which studied the relationship of miR-93 and TGFBR2 in PCa cell lines and specimens. We also detected the impacts of hypoxia on EZH2 and miR-93, and further examined the tumorigenic functions of miR-93 on proliferation and epithelial-mesenchymal transition via a series of experiments. Results TGFBR2 expression was attenuated under hypoxia. Hypoxia-induced EZH2 promoted H3K27me3 which caused TGFBR2 promoter hypermethylation and contributed to its epigenetic silencing in PCa. Besides, miR-93 was significantly upregulated in PCa tissues and cell lines, and negatively correlated with the expression of TGFBR2. Ectopic expression of miR-93 promoted cell proliferation, migration and invasion in PCa, and its expression could also be induced by hypoxia. In addition, TGFBR2 was identified as a bona fide target of miR-93. Conclusions Our findings elucidate diverse hypoxia-regulated pathways including EZH2-mediated hypermethylation and miR-93-induced silencing contribute to attenuation of TGFBR2 expression and promote cancer progression in prostate cancer.
first_indexed 2024-12-11T09:23:32Z
format Article
id doaj.art-4f67ba8c4f6044d69fc2fbb5ae7d6cd3
institution Directory Open Access Journal
issn 1756-9966
language English
last_indexed 2024-12-11T09:23:32Z
publishDate 2018-04-01
publisher BMC
record_format Article
series Journal of Experimental & Clinical Cancer Research
spelling doaj.art-4f67ba8c4f6044d69fc2fbb5ae7d6cd32022-12-22T01:13:11ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662018-04-0137111310.1186/s13046-018-0764-9Attenuation of TGFBR2 expression and tumour progression in prostate cancer involve diverse hypoxia-regulated pathwaysHui Zhou0Guanqing Wu1Xueyou Ma2Jun Xiao3Gan Yu4Chunguang Yang5Nan Xu6Bao Zhang7Jun Zhou8Zhangqun Ye9Zhihua Wang10Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Urology, Aerospace Center Hospital(ASCH)Department of Urology, The third people Hospital of Hubei ProvinceDepartment of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyAbstract Background Dysregulation of transforming growth factor β (TGF-β) signaling and hypoxic microenvironment have respectively been reported to be involved in disease progression in malignancies of prostate. Emerging evidence indicates that downregulation of TGFBR2, a pivotal regulator of TGF-β signaling, may contribute to carcinogenesis and progression of prostate cancer (PCa). However, the biological function and regulatory mechanism of TGFBR2 in PCa remain poorly understood. In this study, we propose to investigate the crosstalk of hypoxia and TGF-β signaling and provide insight into the molecular mechanism underlying the regulatory pathways in PCa. Methods Prostate cancer cell lines were cultured in hypoxia or normoxia to evaluate the effect of hypoxia on TGFBR2 expression. Methylation specific polymerase chain reaction (MSP) and demethylation agents was used to evaluate the methylation regulation of TGFBR2 promoter. Besides, silencing of EZH2 via specific siRNAs or chemical inhibitor was used to validate the regulatory effect of EZH2 on TGFBR2. Moreover, we conducted PCR, western blot, and luciferase assays which studied the relationship of miR-93 and TGFBR2 in PCa cell lines and specimens. We also detected the impacts of hypoxia on EZH2 and miR-93, and further examined the tumorigenic functions of miR-93 on proliferation and epithelial-mesenchymal transition via a series of experiments. Results TGFBR2 expression was attenuated under hypoxia. Hypoxia-induced EZH2 promoted H3K27me3 which caused TGFBR2 promoter hypermethylation and contributed to its epigenetic silencing in PCa. Besides, miR-93 was significantly upregulated in PCa tissues and cell lines, and negatively correlated with the expression of TGFBR2. Ectopic expression of miR-93 promoted cell proliferation, migration and invasion in PCa, and its expression could also be induced by hypoxia. In addition, TGFBR2 was identified as a bona fide target of miR-93. Conclusions Our findings elucidate diverse hypoxia-regulated pathways including EZH2-mediated hypermethylation and miR-93-induced silencing contribute to attenuation of TGFBR2 expression and promote cancer progression in prostate cancer.http://link.springer.com/article/10.1186/s13046-018-0764-9TGFBR2HypoxiaEZH2MicroRNA-93Prostate cancer
spellingShingle Hui Zhou
Guanqing Wu
Xueyou Ma
Jun Xiao
Gan Yu
Chunguang Yang
Nan Xu
Bao Zhang
Jun Zhou
Zhangqun Ye
Zhihua Wang
Attenuation of TGFBR2 expression and tumour progression in prostate cancer involve diverse hypoxia-regulated pathways
Journal of Experimental & Clinical Cancer Research
TGFBR2
Hypoxia
EZH2
MicroRNA-93
Prostate cancer
title Attenuation of TGFBR2 expression and tumour progression in prostate cancer involve diverse hypoxia-regulated pathways
title_full Attenuation of TGFBR2 expression and tumour progression in prostate cancer involve diverse hypoxia-regulated pathways
title_fullStr Attenuation of TGFBR2 expression and tumour progression in prostate cancer involve diverse hypoxia-regulated pathways
title_full_unstemmed Attenuation of TGFBR2 expression and tumour progression in prostate cancer involve diverse hypoxia-regulated pathways
title_short Attenuation of TGFBR2 expression and tumour progression in prostate cancer involve diverse hypoxia-regulated pathways
title_sort attenuation of tgfbr2 expression and tumour progression in prostate cancer involve diverse hypoxia regulated pathways
topic TGFBR2
Hypoxia
EZH2
MicroRNA-93
Prostate cancer
url http://link.springer.com/article/10.1186/s13046-018-0764-9
work_keys_str_mv AT huizhou attenuationoftgfbr2expressionandtumourprogressioninprostatecancerinvolvediversehypoxiaregulatedpathways
AT guanqingwu attenuationoftgfbr2expressionandtumourprogressioninprostatecancerinvolvediversehypoxiaregulatedpathways
AT xueyouma attenuationoftgfbr2expressionandtumourprogressioninprostatecancerinvolvediversehypoxiaregulatedpathways
AT junxiao attenuationoftgfbr2expressionandtumourprogressioninprostatecancerinvolvediversehypoxiaregulatedpathways
AT ganyu attenuationoftgfbr2expressionandtumourprogressioninprostatecancerinvolvediversehypoxiaregulatedpathways
AT chunguangyang attenuationoftgfbr2expressionandtumourprogressioninprostatecancerinvolvediversehypoxiaregulatedpathways
AT nanxu attenuationoftgfbr2expressionandtumourprogressioninprostatecancerinvolvediversehypoxiaregulatedpathways
AT baozhang attenuationoftgfbr2expressionandtumourprogressioninprostatecancerinvolvediversehypoxiaregulatedpathways
AT junzhou attenuationoftgfbr2expressionandtumourprogressioninprostatecancerinvolvediversehypoxiaregulatedpathways
AT zhangqunye attenuationoftgfbr2expressionandtumourprogressioninprostatecancerinvolvediversehypoxiaregulatedpathways
AT zhihuawang attenuationoftgfbr2expressionandtumourprogressioninprostatecancerinvolvediversehypoxiaregulatedpathways